Oxford Instruments Shares Rose Even As Sales Fell

If you had backed Oxford Instruments at the very start of 2026, your view on its US push, China exposure, and margin story probably felt finely balanced. Holding Oxford Instruments from the start of the year would have returned 26.1%, including dividends. That outcome now sits alongside a sharp swing in net margin and a surge in orders linked to AI infrastructure. If you were making that call again today, how much weight would you give to the US market focus versus the China and compliance risks?

On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.

This theme extends beyond Oxford Instruments. See which of 54 AI infrastructure stocks may still merit a closer look.

The Two Oxford Instruments Stories Investors Were Weighing

The shares cost £20.5 at the start of the period, and Oxford Instruments sat between two clear storylines that both sounded plausible.

The bullish Narrative put Fair Value at £23.89, tied to operational changes and a push toward North America. Supporters leaned on assumptions that profit margins could move from 5.2% to 13.1% within three years.

The more cautious Narrative set Fair Value at £18.5 and focused on US China friction and rising compliance demands. That view stressed the risk that export controls and localization could restrict the addressable market.

What The Results Changed For The Oxford Instruments Story

Oxford Instruments reported H2 2026 revenue of £237.7m, slightly below H2 2025, while net income moved from a small loss of £0.2m to a £29.4m profit. Net margin shifted from roughly zero to 12.4%, which gave the optimistic margin thesis some support, although the cautious case on China and compliance was not directly tested.

The takeaway is simple. When a margin story is central, you track reported net income and percentage margin each half year rather than only watching headline sales or the share price.

What Oxford Instruments Buyers Are Really Paying For Now

Oxford Instruments now trades at £25.74 from the start of the year, and the selected bullish Narrative places its Fair Value above that level. The focus is on how effectively current demand, especially around compound semiconductors and AI datacom, might translate into higher profitability.

Instead of asking whether orders arrive, the question moves to execution. A buyer today would need to judge whether Oxford Instruments can keep turning Severn Beach capacity, commercial contracts, and margin efforts into sustained 20% type profitability.

"The main requirement is continued execution on operational simplification and capacity expansion, so margin initiatives and the Severn Beach compound semiconductor facility can translate strong order intake into profitable revenue without prolonged bottlenecks."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

Find Your Own Contrarian Opportunity

What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.

• Company 1 - 20% below our estimate - targets geotechnical packages on larger infrastructure and data center projects using tighter project risk controls.
• Company 2 - 42% below our estimate - advances late stage cardiometabolic and rare disease drugs intended to offset upcoming patent expiries.
• Company 3 - 43% below our estimate - uses a rebuilt cloud tech stack and AI tools to roll out new savings and SME services.

That is three of the list. See every one of the 14 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com